# ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063

Canonical: https://abierto.us/opportunities/36c25526n0394

- Solicitation number: 36C25526N0394
- Notice type: Award notice
- Status: Awarded to Novartis Pharmaceuticals Corporation for $891,650.00
- Department: Department of Veterans Affairs
- Contracting office: 255-Network Contract Office 15 (36C255)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- First posted: August 21, 2026
- Last posted: August 21, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/5f843004e5a54f83afa78a2d3feb9ff9/view

## Description

Ordering Activity / Contracting Office Department of Veterans Affairs Network Contracting Office (NCO 15) 3450 S 4th Street Trafficway Leavenworth, KS 66048 Contract / Order Information FSS Contract Number:

**36F79720D0180 Order Number:**

**36C25526N0394 Requisition / PO Number:**

**657-C60305 Effective Date of Award:**

**August 5, 2026Ordering Period:** August 5, 2026 through February 5, 2027 Method of Solicitation: FSS order under SF 1449, commercial products and commercial services Awardee (Contractor) Novartis Pharmaceuticals Corporation 59 Route 10 East Hanover, NJ 07936 UEI: NG61ZA8TADW3 (as shown on the SF 1449).

**Primary Contractor POC:** Yisell Rodriguez, 201 602 5055, yisell.rodriquez@novartis.com. Place of Delivery / Performance VA St. Louis Health Care System John J. Cochran Veterans Hospital 915 North Grand Boulevard St. Louis, MO 63106 Description of Supplies/Services This award provides one proprietary radiopharmaceutical agent, PLUVICTO (Lutetium Lu 177 vipivotide tetraxetan), NDC 69488 0010 6, for use by Nuclear Medicine at VA St. Louis Health Care System.

PLUVICTO is indicated for adult patients with PSMA positive metastatic castration resistant prostate cancer who have been treated with androgen receptor pathway inhibition and taxane based chemotherapy. The period of performance supports diagnostic and therapeutic use of this radiopharmaceutical in accordance with the Statement of Work included in the SF 1449. Line Item and Pricing CLIN 0001: PLUVICTO Lutetium Lu 177 vipivotide tetraxetan, NDC 69488 0010 6. Quantity: 26 Each.

**Unit Price:** 34,294.26.

**Extended Amount:** 891,650.76.

**Total Award Amount:** 891,650.76. Funding / Accounting Data As shown on SF 1449: 657 26 4 1642 0063 / 657 3660 / 160 1642 822900 2580 / 0100L00H6 (Accounting and Appropriation Data). Invoice and Payment Instructions Invoices shall be submitted monthly in arrears and must reference PO number 657 C60305 and Order number 36C25526N0394. All invoices shall be submitted electronically in accordance with VAAR 852.232 72, via the VA Financial Services Center e-invoicing system (Austin, TX). Payment will be made by: Department of Veterans Affairs Financial Services Center, Austin, TX (see SF 1449 Block 18a and Continuation Page for full details).

**Contract Administration / Points of Contact Contracting Officer:** Michael P. Murphy Department of Veterans Affairs Network Contracting Office (NCO 15) 3450 S 4th Street Trafficway, Leavenworth, KS 66048 Email: michael.murphy7@va.gov Phone:

**913 946 1970 Facility Point of Contact (Pluvicto):** Mark Lauridsen VA St. Louis Health Care System Email: mark.lauridsen@va.gov Phone: 314 652 4100 ext. 66522 The Contracting Officer retains sole authority to approve changes or modifications affecting price, quantity, or quality of performance under this contract. The Contracting Officer s Representative (COR) will be designated separately in accordance with VAAR 852.270 1 and will be responsible for technical and administrative oversight.

Special Terms and Conditions This order is subject to the terms and conditions of FSS Contract 36F79720D0180 and all clauses incorporated by reference on SF 1449, including VAAR 852.247 71 (Delivery Location), VAAR 852.232 72 (Electronic Submission of Payment Requests), VAAR 852.203 70 (Commercial Advertising), VAAR 852.242 71 (Administrative Contracting Officer), and VAAR 852.246 71 (Rejected Goods).

The VA St. Louis Health Care System s business hours and applicable federal holidays are as set forth in the Statement of Work, and contract performance monitoring will be conducted in accordance with VA quality assurance procedures described therein.

## Award on USAspending

- Recipient: Novartis Pharmaceuticals Corporation (UEI NG61ZA8TADW3)
- Contract: 36C25526N0394 under 36F79720D0180, delivery order
- Obligated: $891,650.76
- Competition: Full and Open Competition, 1 offers received
- Link: solicitation number 36C25526N0394 was reused as the contract number; same awarding office 36C255 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_36C25526N0394_3600_36F79720D0180_3600/


## Publications

- August 21, 2026: Award notice. Notice 5f843004e5a54f83afa78a2d3feb9ff9. https://sam.gov/workspace/contract/opp/5f843004e5a54f83afa78a2d3feb9ff9/view

## Points of contact

- Michael P Murphy, Michael Murphy, michael.murphy7@va.gov, 913-946-1963

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/36c25526n0394.